Injectable EE + DRSP PLGA Microcapsules
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Injectable
-
Intended Duration:
- Long-Acting
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): Bayer
Details
- API: Ethinyl Estradiol, Drospirenone
- Target: Estrogen Receptor, Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: PLGA
- Regimen: Undetermined
- MPT: Not Potential MPT
Product Status
No evidence of active development after 2013
History
Limited public information. Bayer's flagship combined oral contraceptives Yaz and Yasmin contain both EE and DRSP. Based on a 2012 publication, this hormone combination was considered for use in a long-acting microsphere-based injectable.